- Global Pharma News & Resources

Global Autism Spectrum Disorder (ASD) Market Insights, Epidemiology and Market Forecast 2016-2018 & 2027 -

The "Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027" drug pipelines has been added to's offering.

Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027' report delivers an in-depth understanding of the disease, historical & forecasted epidemiology as well as the market trends of Autism Spectrum Disorder (ASD) in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

The Report provides the current treatment practices, emerging drugs, market share of the individual therapies, current and forecasted market size of Autism Spectrum Disorder (ASD) from 2016 to 2027 segmented by seven major markets. The Report also covers current treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assess underlying potential of the market.

Autism Spectrum Disorder (ASD) Report Insights

  • Patient Population
  • Therapeutic Approaches
  • Pipeline Analysis
  • Market Size and Trends
  • Market Opportunities
  • Impact of upcoming Therapies

Autism Spectrum Disorder (ASD) Report Key Strengths

  • 10 Years Forecast
  • 7MM Coverage
  • Epidemiology Segmentation
  • Key Cross Competition
  • Highly Analyzed Market
  • Drugs Uptake

ASD Report Assessment

  • Current Treatment Practices
  • Unmet Needs
  • Pipeline Product Profiles
  • Market Attractiveness
  • Market Drivers and Barriers

Key Topics Covered:

1. Key Insights

2. Autism Spectrum Disorder Market Overview at a Glance

3. Disease Overview: Autism Spectrum Disorder

4. Epidemiology and Patient Population

5. Country Wise-Epidemiology of Autism Spectrum Disorder

6. Treatment Practices

7. Treatment Guidelines and Recommendations

8. Treatment Algorithm

9. Unmet Needs

10. Marketed Drugs

11. Emerging Therapies

12. Autism Spectrum Disorder: 7 Major Market Analysis

13. Market Outlook by Country

14. The United States: Market Outlook

15. EU-5 Countries: Market Outlook

16. Japan: Market Outlook

17. Market Drivers

18. Market Barriers

19. Appendix

Companies Mentioned

  • Roche
  • Neurochlore/Servier
  • Curemark
  • Yamo Pharmaceuticals
  • Johnson and Johnson
  • Otsuka Pharmaceutical
  • Neurim Pharmaceuticals

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 05-Dec-2018